Skip to content
TrackPodcasts
businessJul 26, 202233:15pending

Buying Public Companies

M&A Science

About this episode

Pranjal Gambhir, and Doretta Mistras, Managing Director - Global Investment Banking, Healthcare at Citi

The M&A process varies when dealing with a public vs private company. To many, acquiring a public company is more ideal. First-time acquirers need to be aware of the differences between acquiring a public company and acquiring a private company.

In this episode of the M&A Science Podcast, Pranjal Gambhir and Doretta Mistras, both Managing Directors, Global Investment Banking, Healthcare at Citi, talk about how to buy public companies. 

To check out Affinity's 2022 M&A Benchmark Report, download it for free at http://affinity.co/kison

Liked today's episode? Unlock over 50 courses taught by top-tier M&A practitioners by joining the M&A Science Academy. Use code "podcast" on the sign-up page for a 20% discount, available on either monthly or annual plans. https://www.mascience.com/academy

Want to learn about upcoming interviews, events, and industry trends? Sign up for our weekly newsletter. https://www.mascience.com/newsletter-signup

If you're a head of corporate development and looking to build up a world-class M&A team, reach out to me at [email protected].

This episode is sponsored by FirmRoom, the fastest virtual data room used to get deals done. Leave the pay-per-page world behind by going to https://firmroom.com/

Get every episode summarized

Each time M&A Science publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Hosts & guests

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

Buying Public Companies

M&A Science

0:00
33:15

More episodes

More from M&A Science

View all episodes →